PHR
Get informed when a big investor buys or sells
+ FollowUndervalued by 135.6% based on the discounted cash flow analysis.
| Market cap | $773.27 Million |
|---|---|
| Enterprise Value | $830.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.04 |
| Beta | 0.87 |
| Outstanding Shares | 60,944,962 |
| P/E Ratio | 82.19 |
|---|---|
| PEG | -30.94 |
| Price to Sales | 1.58 |
| Price to Book Ratio | 2.52 |
| Enterprise Value to Revenue | 1.68 |
| Enterprise Value to EBIT | -915.85 |
| Enterprise Value to Net Income | -85 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.37 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3356▼ 313.28% |
|---|---|
| Total Calls | 29,500▼ 64.11% |
| Total Puts | 9,900▼ 96.53% |
Holdings and activity of institutional investors.
| Ownership % | 22.24%▼ 76.02% |
|---|---|
| Total Invested | $139.25M▼ 71.89% |
| Investors Holding | 76▼ 176.00% |
No data
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...